Before 2020, SPACs, or Special Purpose Acquisition Companies, were considered to be high-risk investments due to a lack of financial history and a variety of challenges that the companies face to comply with the SEC after they start trading. However, we have seen a lot of renewed interest in SPACs.... |
Good MorningThe major indices wobbled a bit in early trading on Tuesday but soon stabilized and began moving higher. The move was supported by comments from Fed Chief Jerome Powell and Secretary of the Treasury Steven Mnuchin in testimony to Congress. The two say the economy is rebounding despite obvious risks and stand ready to add support as needed.
The S&P 500 advanced more than 1.20% by the end of the day but the tech-heavy NASDAQ Composite led the session. The index appears to be putting in a bottom after the rout in FAANG names that brought it down to correction levels. With the third-quarter earnings season at hand, the odds of a deeper correction are getting hard to judge. This week's reports from Nike, Costco, and Carmax will dominate the market’s attention, any signs of strength or weakness are sure to spur investor activity.
Featured: INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad) 
| Stocks | | |
Before 2020, SPACs, or Special Purpose Acquisition Companies, were considered to be high-risk investments due to a lack of financial history and a variety of challenges that the companies face to comply with the SEC after they start trading. However, we have seen a lot of renewed interest in SPACs... Read the Full Story |
| | Markets | | | UPS Delivers eCommerce Gains
The chart of UPS (NYSE:UPS) looks like a stock about to pop. The stock has been trending in a tight range at an all-time high for weeks and the indicators are setting up nicely. Looking at the bigger picture, the fundamental story is more than bullish, and one tha... Read the Full Story |
| Markets | | |
It’s hard to find a bullish argument for Aurora Cannabis (NYSE:ACB). ACB stock has fallen 74% for the year. And that’s not the worst news. The company’s stock has also fallen 16% since the middle of March at the onset of the pandemic.
And while the stock got one bounce of nearly... Read the Full Story |
| From Our Partners | | I made a mistake.
A mistake I feel very foolish about.
After speaking with Donald Trump and some of his advisors, I believed him.
I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years.
But I was wrong. | | Let me show you exactly what we’re doing to prepare. |
| Markets | | | In August, used car prices recorded their highest monthly gain since March 1969, with prices jumping 5.4% from July. Those gains followed a strong July, when used car prices increased 3.4% over June levels.
People are investing a lot of money into used cars, and automotive aftermarket parts supplie... Read the Full Story |
| Markets | | | Walmart Has Corrected, It’s Time To Buy Some More
Shares of Walmart (NYSE:WMT) hit an all-time earlier this month driven by rising revenue, growing profits, and tailwinds from the pandemic. Since then, the stock has corrected more than 10% and offering up an attractive entry for long-term inv... Read the Full Story |
| From Our Partners | | CPA and CFA says you have WAY too many stocks - just buy these 3
After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%. | | Click here to view… |
| The Early Bird Stock Of The Day Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. | | View Today's Stock Pick |
|
| |
|
|
